# OnCo record nct05652920 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05652920/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05652920", "NCT05652920" ;
  schema:name "Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC"@en ;
  schema:alternateName "BEACON"@en ;
  schema:description "A phase 1/2 trial of Ori-C101 in hepatocellular carcinoma, run by OriCell Therapeutics Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05652920/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05652920> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2022-12-15" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/hcc-advanced/> .